Elevated levels of serum SP-A in chronic eosinophilic pneumonia Source: Eur Respir J 2001; 18: Suppl. 33, 409s Year: 2001
CCL20 level in bronchoalveolar lavage fluid is correlated with the levels of serum indications in patients with pulmonary sarcoidosis Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010
Elevated NT-3 levels in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 586s Year: 2007
Serum and BALF levels of YKL-40 in patients with alveolar proteinosis Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010
Elevated levels of chemokines in bronchoalveolar lavage fluid as diagnostic markers for predicting the development of post-transplant obliterative bronchiolitis Source: Eur Respir J 2001; 18: Suppl. 33, 180s Year: 2001
CCR5 expression and CC-chemokine levels in broncho-alveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2002; 20: Suppl. 38, 598s Year: 2002
Soluble Fas-ligand levels in bronchoalveolar lavage fluid before and after interferon-γ-1b treatment in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 334s Year: 2005
High levels of pepsin A in bronchoalveolar lavage fluid of patients with exacerbation of interstitial lung diseases and no evidence of infection Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010
Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) in patients with idiopathic pulmonary fibrosis-usual interstitial pneumonia (IPF-UIP) using SELDI-mass spectrometry Source: Annual Congress 2007 - Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis Year: 2007
Determination of CD4, CD8 and IL-8 levels in serum and BAL fluid of patients with pulmonary anthracosis Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018
Tryptase levels in bronchoalveolar lavage fluid (BALF) may predict the recurrence and chronicity of eosinophilic pneumonia Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019
Increased Clara cell protein 16 levels in the bronchoalveolar lavage fluid of idiopathic pulmonary fibrosis patients Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008
Studies on interferon-gamma (IFN-γ) expression in lower airways of patients with idiopathic pulmonary fibrosis (IPF), sarcoidosis and pneumoconioses. Lower IFN-γ levels in bronchoalveolar lavage (BAL) supernatants of IPF subgroup with decrease Source: Eur Respir J 2007; 30: Suppl. 51, 121s Year: 2007
Increased levels of osteopontin in sputum supernatant in patients with COPD Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012
BALF cells expression phenotypes and cytokine levels in BALF supernatant in fibrosing interstitial lung diseases Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012
Levels of cytokines and chemokines in BAL fluid in patients with idiopathic interstitial pneumonitis and collagen vascular disease associated interstitial pneumonitis Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011
Elevated transforming growth factor (TGF)-β1 and thrombospondin (TSP)-1 levels in bronchoalveolar lavage (BAL) fluid of patients with pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 83s Year: 2003
Relationship between IL-8, IL-10, MMP-9 and morphological findings in BAL fluid of patients with interstitial lung diseases Source: Eur Respir J 2003; 22: Suppl. 45, 225s Year: 2003
Levels of TNF-a in blood serum and BALF from children with bronchiolitis obliterans depending on severity of disease Source: Eur Respir J 2005; 26: Suppl. 49, 29s Year: 2005
Increased BALF eosinophils and underlying interstitial lung disease Source: Eur Respir J 2005; 26: Suppl. 49, 541s Year: 2005